Article ID Journal Published Year Pages File Type
2567472 Pulmonary Pharmacology & Therapeutics 2010 8 Pages PDF
Abstract
This study established a safe dose range and demonstrated the feasibility of prolonged, repeated dosing of pf-tPA. High doses (≥1 mg/kg/d) were associated with pulmonary hemorrhage that may be due, in part, to accumulation of drug in the lungs.
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
, , , , , , ,